IMPACTS Trial: Investigation of the Modulation of Phospholipase in Acute Chest Syndrome

Clinical trial NCT00434473 · COMPLETED

Trial details

NCT number: NCT00434473
Sponsor: Anthera Pharmaceuticals
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Sickle Cell Disease Vaso-occlusive Crisis Acute Chest Syndrome

Start date: 2006-12-01
Primary completion: 2009-08-01
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.